FrancophonIA/ELRC3.0 huggingface dataset:
English: At week 16, the mean total daily insulin dose was 0.88 vs 1.01 units/kg in the Ryzodeg and insulin detemir arms, respectively.
Danish: Ved uge 16 var den gennemsnitslige totale daglige insulindosis 0,88 versus 1,01 enheder/kg i armene med henholdsvis Ryzodeg og insulin detemir.
English: • If you want to change your usual diet, check with your doctor, pharmacist or nurse first as a change in diet may alter your need for insulin.
Danish: • Hvis du vil ændre din sædvanlige kost, skal du først tale med lægen, sundhedspersonalet eller apoteket, da en kostændring kan ændre dit insulinbehov.
English: If you stop using your insulin, this could lead to a very high blood sugar level and ketoacidosis (a condition with too much acid in the blood), see advice in section 4 ‘Too high blood sugar'.
Danish: Hvis du holder op med at tage insulin, kan det føre til et meget højt blodsukkerniveau og ketoacidose (en tilstand, hvor der er for meget syre i blodet) se informationen i punkt 4 "For højt blodsukker".
English: Any waste material should be disposed of in accordance with local requirements.
Danish: Ikke anvendt lægemiddel samt affald heraf skal bortskaffes i henhold til lokale retningslinjer.
English: Too high blood sugar may happen if you:
Danish: For højt blodsukker kan forekomme, hvis du:
English: Concomitant diseases in the kidney, liver or diseases affecting the adrenal, pituitary or thyroid gland may require changes in the insulin dose.
Danish: Samtidige sygdomme i nyrer eller lever eller sygdomme, som påvirker binyrer, hypofyse eller thyreoidea, kan nødvendiggøre ændringer i insulindosis.
English: The trial had a median duration of 2 years and compared the cardiovascular safety of insulin degludec vs insulin glargine (100 units/mL) in 7,637 patients with type 2 diabetes mellitus at high risk of cardiovascular events.
Danish: Studiet havde en gennemsnitlig varighed på 2 år og sammenlignede den kardiovaskulære sikkerhed af insulin degludec med insulin glargin (100 enheder/ml) hos 7.637 patienter med type 2-diabetes mellitus med høj risiko for kardiovaskulære hændelser.
English: Make sure the dose counter shows 2.
Danish: Kontrollér, at dosistælleren viser 2.
English: demonstrated similar glycaemic control (HbA1c) compared with BIAsp 30 b.i.d.
Danish: viste en glykæmisk kontrol (HbA1c) svarende til BIAsp 30 b.i.d.
English: An updated RMP should be submitted: - At the request of the European Medicines Agency; - Whenever the risk management system is modfied, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached.
Danish: • når risikostyringssystemet ændres, særlig som følge af, at der er modtaget nye oplysninger, der kan medføre en væsentlig ændring i benefit/risk-forholdet, eller som følge af, at en vigtig milepæl (lægemiddelovervågning eller risikominimering) er nået.
English: • The best places to inject are the front of your waist (abdomen), upper arms or the front of your thighs.
Danish: • De bedste steder til injektion er foran på maveskindet, overarmen eller foran på låret.
English: )1 Insulin users
Danish: )1 insulinbrugere
English: • The active substances are insulin degludec and insulin aspart.
Danish: • Aktive stoffer: insulin degludec og insulin aspart.
English: The pharmacokinetic properties of Ryzodeg in type 1 diabetes mellitus were investigated in children (6-11 years) and adolescents (12-18 years) and compared to adults after single dose administration.
Danish: De farmakokinetiske egenskaber af Ryzodeg ved type 1-diabetes mellitus er undersøgt hos børn (611 år) og unge (12-18 år) og sammenlignet med voksne efter enkeltdosisadministration.
English: • Rapid-acting insulin called insulin aspart, this lowers your blood sugar soon after you inject it.
Danish: • Hurtigtvirkende insulin kaldet insulin aspart, det sænker blodsukkeret hurtigt efter, at du har injiceret det.
English: Do not place the used needle in household waste.
Danish: Afskaf ikke brugte nåle sammen med husholdningsaffald.
English: The pharmacokinetic properties of insulin degludec in children (1-11 years) and adolescents (1218 years) were at steady state comparable to those observed in adults with type 1 diabetes mellitus.
Danish: Insulin degludecs farmakokinetiske egenskaber hos børn (1-11 år) og unge (12-18 år) ved steady state var sammenlignelige med dem som var observeret hos voksne med type 1-diabetes mellitus.
English: This medicinal product is to be used once daily at mealtime in combination with short-/rapid-acting insulin at the remaining meals followed by individual dosage adjustments.
Danish: Dette lægemiddel skal anvendes én gang dagligt ved et måltid i kombination med korttids/hurtigtvirkende insulin ved de øvrige måltider efterfulgt af individuelle dosisjusteringer.
English: Injection site reactions (including injection site haematoma, pain, haemorrhage, erythema, nodules, swelling, discolouration, pruritus, warmth and injection site mass) occurred in patients treated with Ryzodeg.
Danish: Reaktioner på injektionsstedet (inklusive hæmatom, smerter, hæmoragi, erytem, knuder, hævelse, misfarvning, pruritus, varme samt fortykkelse på injektionsstedet) forekom hos patienter i behandling med Ryzodeg.
English: • Basal insulin called insulin degludec, this has a long blood sugar-lowering effect.
Danish: • Basalinsulin kaldet insulin degludec, det har en langvarig blodsukkersænkende virkning.
English: Do not use the insulin scale, it only shows approximately how much insulin is left in your pen.
Danish: Du må ikke bruge insulinskalaen, da den ikke nøjagtigt viser, hvor meget insulin der er tilbage i pennen.
English: Solution for injection (FlexTouch) Multipack: 10 (2 packs of 5) 3 mL pre-filled pens
Danish: Injektionsvæske, opløsning (FlexTouch) Multipakning: 10 (2 pakker a 5) 3 ml fyldte penne
English: Ryzodeg').
Danish: "Opbevaring").
English: Both treatments improved glycaemic control with an estimated mean reduction with Ryzodeg (-1.23%) against IDeg plus IAsp (-1.42%) for the primary endpoint of change from baseline in HbA1c at 26 weeks.
Danish: Begge behandlinger forbedrede den glykæmiske kontrol med en estimeret gennemsnitlig reduktion med Ryzodeg (-1,23%) sammenlignet med IDeg plus IAsp (-1,42%) for det primære ændrings-endepunkt af HbA1c fra baseline ved 26 uger.
English: A lower rate of nocturnal hypoglycaemia (defined as episodes between midnight and 6 a.m. confirmed by plasma glucose < 3.1 mmol/L or by patient needing third party assistance) was observed with Ryzodeg relative to IGlar (Table 1).
Danish: En lavere forekomst af natlig hypoglykæmi (defineret som episoder mellem midnat og kl. 6 bekræftet med plasmaglucose < 3,1 mmol/l eller ved, at patienten havde behov for hjælp fra andre) blev observeret med Ryzodeg i forhold til IGlar (tabel 1).
English: EU/1/12/806/001 1 pen of 3 mL EU/1/12/806/002 1 pen of 3 mL and 7 NovoFine needles EU/1/12/806/003 1 pen of 3 mL and 7 NovoTwist needles EU/1/12/806/004 5 pens of 3 mL
Danish: EU/1/12/806/001 1 pen a 3 ml EU/1/12/806/002 1 pen a 3 ml og 7 NovoFine engangsålne EU/1/12/806/003 1 pen a 3 ml og 7 NovoTwist engangsnåle EU/1/12/806/004 5 penne a 3 ml
English: Total exposure with Ryzodeg increases proportionally with increasing dose of the basal component (insulin degludec) and the mealtime component (insulin aspart) in type 1 and type 2 diabetes mellitus.
Danish: Den totale eksponering med Ryzodeg stiger proportionalt med stigende dosis af basalkomponenten (insulin degludec) og måltidskomponenten (insulin aspart) ved type 1- og type 2-diabetes mellitus.
English: Substances added to Ryzodeg may cause degradation of insulin degludec and/or insulin aspart.
Danish: Lægemidler, som tilsættes til Ryzodeg, kan medføre nedbrydning af insulin degludec og/eller insulin aspart.
English: • angiotensin converting enzyme (ACE) inhibitors, for some heart problems or high blood pressure.
Danish: • angiotensin-konverteringsenzymhæmmere (ACE-hæmmere), mod visse hjertelidelser eller forhøjet blodtryk.
English: Solution for injection (FlexTouch) 5 x 3 mL.
Danish: Injektionsvæske, opløsning (FlexTouch) 5 x 3 ml.
English: The rates (events per patient-year of exposure) of confirmed hypoglycaemia (ISPAD 2009 definition: 46.23 vs 49.55) and nocturnal confirmed hypoglycaemia (5.77 vs 5.40) were comparable with Ryzodeg vs insulin detemir whereas the rate of severe hypoglycaemia (0.26 vs 0.07) was higher in the Ryzodeg arm although the difference was not statistically significant.
Danish: Hyppigheden (hændelser per eksponeret patientår) af bekræftet hypoglykæmi (ISPAD 2009 definition 46,23 versus 49,55) og natlig bekræftet hypoglykæmi (5,77 versus 5,40) var sammenlignelig mellem Ryzodeg versus insulin detemir, hvorimod hyppigheden af alvorlig hypoglykæmi (0,26 versus 0,07)
English: See your delivery system manual for further instructions.
Danish: Se brugervejledningen til dispenseringssystemet for yderligere oplysninger.
English: The frequency, type and severity of adverse reactions in the paediatric population do not indicate differences to the experience in the general diabetes population with the exception of a signal of higher occurrence of severe hypoglycaemia compared to a basalbolus regimen in the paediatric population, particularly in children 2 to 5 years old (see section 4.2, 4.4 and 5.1).
Danish: Hyppighed, type og sværhedsgrad af bivirkninger hos den pædiatriske population indikerer ingen forskel i forhold til erfaringen fra den generelle diabetes-population med undtagelse af en indikation på øget forekomst af alvorlig hypoglykæmi sammenlignet med basalbolusregime hos den pædiatriske population, særligt hos børn i alderen 2 til 5 år (se pkt.
English: 3 Confirmed hypoglycaemia was defined as episodes confirmed by plasma glucose < 3.1 mmol/L or by the patient needing third party assistance.
Danish: 3 Bekræftet hypoglykæmi blev defineret som episoder bekræftet med plasmaglucose < 3,1 mmol/l eller ved, at patienten havde behov for hjælp fra andre.
English: Ryzodeg has a rapid onset of action occurring soon after injection providing mealtime coverage while the basal component has a flat and stable action profile providing continuous coverage of the basal insulin requirements.
Danish: Ryzodeg har en hurtig virkning, som indtræder kort tid efter injektionen og giver måltidsdækning, mens basalkomponenten har en flad og stabil virkningsprofil, som giver kontinuerlig dækning af behovet for basalinsulin.
English: Too low blood sugar may happen if you:
Danish: For lavt blodsukker kan forekomme, hvis du:
English: was compared with IDeg o.d. plus IAsp (2-4 daily injections) in patients with type 2 diabetes mellitus treated with basal insulin in need of treatment intensification with mealtime insulin.
Danish: blev sammelignet med IDeg o.d. plus IAsp (2-4 daglige injektioner) hos patienter med type 2-diabetes mellitus, der blev behandlet med basal insulin, og med behov for intensiveret behandling med måltidsinsulin.
English: Ryzodeg can be used in adolescents and children from the age of 2 years with diabetes mellitus.
Danish: Ryzodeg kan anvendes til unge og børn fra 2 år med diabetes.
English: Ryzodeg can be administered once daily at mealtime in combination with short-/rapid-acting insulin at the remaining meals.
Danish: Ryzodeg kan administreres én gang dagligt sammen med et måltid i kombination med korttids/hurtigtvirkende insulin ved de øvrige måltider.
English: 1 Once-daily regimen + Metformin
Danish: 1 Regime én gang dagligt + metformin.
English: As Ryzodeg contains a rapid-acting mealtime insulin (insulin aspart), prandial glycaemic control at the dosing meal is improved relative to administering basal insulin only; see trial results in Table 1.
Danish: Da Ryzodeg indeholder et hurtigtvirkende måltidsinsulin (insulin aspart), er prandial glykæmisk kontrol ved doseringsmåltidet forbedret med Ryzodeg i forhold til basalinsulin alene, se studie resultat i tabel 1).
English: with IDeg o.d. plus IAsp 2-4 times daily) in type 2 diabetes mellitus.
Danish: med IDeg o.d. plus IAsp 2-4 gange dagligt) ved type 2-diabetes mellitus.
English: Talk to your doctor, pharmacist or nurse before using Ryzodeg.
Danish: Kontakt lægen, apotekspersonalet eller sundhedspersonalet, før du tager Ryzodeg.
English: • how much Ryzodeg you will need each day and at which meal(s) • when to check your blood sugar level and if you need a higher or lower dose.
Danish: • hvornår dit blodsukkerniveau skal kontrolleres, og om du har behov for en højere eller lavere dosis.
English: The pre-filled pen can provide a dose of 1-80 units in one injection in steps of 1 unit.
Danish: Den fyldte pen giver en dosis på 1-80 enheder i én injektion i trin af 1 enhed.
English: Insulin degludec monomers gradually separate from the multi-hexamers thus resulting in a slow and continuous delivery of insulin degludec into the circulation.
Danish: Insulin degludec-monomerer separeres gradvist fra multihexamererne, hvilket giver en langsom og kontinuerlig frigivelse af insulin degludec til kredsløbet.
English: Fasting Plasma Glucose (FPG) (mmol/L)
Danish: Fasteplasmaglucose (FPG) (mmol/l)
English: %: Percentage of subjects with a first EAC confirmed event relative to the number of randomised subjects.
Danish: N: Antal forsøgspersoner med en førstegangshændelse bekræftet under studiet via EAC. %: Procentdel af forsøgspersoner med en førstegangshændelse bekræftet via EAC i forhold til antallet af randomiserede forsøgspersoner.
English: If you stop using Ryzodeg
Danish: Hvis du holder op med at tage Ryzodeg
English: In two trials combining insulin and OAD treatment in both insulin-naïve (insulin initiation) and insulin-using (insulin intensification) patients with type 2 diabetes mellitus, Ryzodeg o.d. demonstrated similar glycaemic control (HbA1c) compared to IGlar (administered according to label) (Table 1).
Danish: I to studier, der kombinerer insulin og OAD behandling hos både insulinnaive patienter (initiering af insulin) og insulinbrugere (intensivering af insulin) med type 2-diabetes mellitus, viste Ryzodeg o.d. en glykæmisk kontrol (HbA1c) svarende til IGlars (administreret ifølge etiket)(tabel 1).
English: • Check the name and strength on the label to make sure it is Ryzodeg 100 units/mL.
Danish: • Kontrollér navnet og styrken på etiketten for at sikre dig, at det er Ryzodeg 100 enheder/ml.
English: )2 Insulin users
Danish: )2 insulinbrugere
English: In patients with type 1 diabetes mellitus, treatment with Ryzodeg o.d. plus IAsp for the remaining meals demonstrated similar glycaemic control (HbA1c and fasting plasma glucose) with a lower rate of nocturnal hypoglycaemia compared to a basal/bolus regimen with IDet plus IAsp at all meals (Table
Danish: Hos patienter med type 1-diabetes mellitus viste behandling med Ryzodeg o.d. plus IAsp til de øvrige måltider en tilsvarende glykæmisk kontrol (HbA1c og faste-plasmaglucose) med en lavere forekomst af natlig hypoglykæmi end et basal-/bolusregime med IDet plus IAsp ved alle måltider (tabel 3).
English: Use only clear, colourless solution Single patient use only Do not withdraw solution from the pen
Danish: Brug kun en klar, farveløs opløsning Kun til individuel brug Udtag ikke opløsning fra pennen
English: Other medicines and Ryzodeg
Danish: Brug af anden medicin sammen med Ryzodeg
English: Based on results from clinical trials, the frequency, type and severity of adverse reactions observed in the elderly and in patients with renal or hepatic impairment do not indicate any differences to the broader experience in the general population.
Danish: Resultater fra kliniske studier indikerer ikke nogen forskel i bivirkningernes hyppighed, type og sværhedsgrad, observeret hos ældre samt hos patienter med nedsat nyre- eller leverfunktion, i forhold til den bredere erfaring i den generelle patientpopulation.
English: In one trial of patients with type 2 diabetes mellitus treated with basal insulin, in need of treatment intensification with mealtime insulin, Ryzodeg o.d. was compared to IGlar o.d. plus IAsp o.d. over 26 weeks.
Danish: I et studie med patienter med type 2-diabetes mellitus behandlet med basal insulin, der havde behov for intensificeret behandling med måltidsinsulin, blev Ryzodeg o.d. sammenlignet med IGlar o.d. plus IAsp o.d. i en periode på 26 uger.
English: Nocturnal confirmed3
Danish: Bekræftet natlig 3
English: Pack sizes of 1 (with or without needles), 5 (without needles) and multipack containing 10 (2 packs of 5) (without needles) pre-filled pens.
Danish: Pakningsstørrelser med 1 (med eller uden nåle), 5 (uden nåle) og multipakning indeholdende 10 (2 pakker a 5) (uden nåle) fyldte penne.
English: Steady-state serum concentration of the basal component (insulin degludec) is reached after 2-3 days of daily Ryzodeg administration.
Danish: Steady state-serumkoncentration af basalkomponenten (insulin degludec) nås efter 23 dages daglig administration af Ryzodeg.
English: There is no experience with the use of Ryzodeg in children below the age of 2 years.
Danish: Der er ingen erfaringer med anvendelse af Ryzodeg til børn under 2 år.
English: Ryzodeg cartridge 100
Danish: Ryzodeg cylinderampul 100
English: EU/1/12/806/005 10 pens of 3 mL
Danish: EU/1/12/806/005 10 penne a 3 ml
English: Ryzodeg showed a lower rate of nocturnal hypoglycaemia compared to IGlar o.d. plus IAsp during 26 weeks (0.42 vs 0.76 estimated rates per patient year of exposure) and 38 weeks (0.51 vs 0.83 estimated rates per patient year of exposure).
Danish: Ryzodeg viste en lavere hyppighed af natlig hypoglykæmi sammenlignet med IGlar o.d. plus IAsp over en periode på 26 uger (estimeret hyppighed på 0,42 vs 0,76 per eksponeret patientår) og 38 uger (estimeret hyppighed på 0,51 vs 0,83 per eksponeret patientår).
English: Fatty tissue under the skin may shrink (lipoatrophy) or get thicker (lipohypertrophy).
Danish: Fedtvævet under huden kan skrumpe ind (lipoatrofi) eller fortykkes (lipohypertrofi).
English: • The other ingredients are glycerol, metacresol, phenol, sodium chloride, zinc acetate, hydrochloric acid and sodium hydroxide (for pH adjustment) and water for injections (see section 2).
Danish: • Øvrige indholdsstoffer: glycerol, metacresol, phenol, natriumchlorid, zinkacetat, saltsyre og natriumhydroxid (til pH-justering) og vand til injektionsvæsker (se punkt 2).
English: Ryzodeg administered once daily o.d. was compared to insulin glargine (100 units/mL) (IGlar) o.d. in two trials in type 2 diabetes mellitus (Table 1).
Danish: Ryzodeg givet én gang dagligt (o.d.) blev sammenlignet med insulin glargin (100 enheder/ml) (IGlar) o.d. i to studier med type 2-diabetes mellitus (tabel 1).
English: The pre-filled pen delivers 1-80 units in steps of 1 unit.
Danish: Den fyldte pen leverer 1-80 enheder i trin af 1 enhed.
English: • if the cartridge is damaged or has not been stored correctly (see section 5 ‘How to store
Danish: • hvis cylinderampullen er beskadiget eller ikke har været opbevaret korrekt (se punkt 5
English: Ryzodeg o.d. demonstrated similar glycaemic control (HbA1c) compared to IGlar o.d. plus IAsp o.d. after 26 weeks (the estimated mean reductions are -1.01% vs -1.09%).
Danish: Ryzodeg o.d. viste tilsvarende glykæmisk kontrol (HbA1c) sammenlignet med IGlar o.d. plus IAsp o.d. efter 26 uger (de estimerede gennemsnitlige reduktioner var -1,01% vs -1,09%).
English: Ryzodeg is used to treat diabetes mellitus in adults, adolescents and children from the age of 2 years.
Danish: Ryzodeg anvendes til at behandle sukkersyge (diabetes mellitus) hos voksne, unge og børn fra 2 år.
English: Patients with type 2 diabetes mellitus Ryzodeg can be administered once or twice daily with the main meal(s) alone, in combination with oral antidiabetic medicinal products, and in combination with bolus insulin (see section 5.1).
Danish: Ryzodeg kan administreres alene én eller to gange dagligt sammen med et hovedmåltid, i kombination med orale antidiabetika, samt i kombination med bolusinsulin (se pkt.
English: 1 Twice-daily regimen ± metformin ± pioglitazone ± DPP-4 inhibitor 2 Twice-daily regimen ± metformin
Danish: 1 Regime to gange dagligt ± metformin ± pioglitazon ± DPP-4-inhibitor.
English: in two trials in type 2 diabetes mellitus (Table 2) and to insulin degludec (IDeg) o.d. plus insulin aspart (IAsp) 2-4 times daily in one trial in type 2 diabetes mellitus.
Danish: i to studier med type 2-diabetes mellitus (tabel 2), og med insulin degludec (IDeg) o.d plus insulin aspart (IAsp) 2-4 gange dagligt i et studie med type 2-diabetes mellitus.
English: Pack sizes of 1 (with or without needles), 5 (without needles) and multipack of 10 (2 x 5) (without needles) pre-filled pens of 3 mL.
Danish: Pakningsstørrelser med 1 (med eller uden nåle), 5 (uden nåle) og multipakke med 10 (2 x 5) (uden nåle) fyldte penne a 3 ml.
English: There is no experience with the use of this medicine in children below the age of 2 years.
Danish: Der er ingen erfaringer med anvendelse af dette lægemiddel til børn under 2 år.
English: • you experience rapid heartbeat or feeling dizzy.
Danish: • du får hjertebanken og føler dig svimmel
English: Ryzodeg can be used in renal and hepatic impaired patients.
Danish: Ryzodeg kan anvendes til patienter med nedsat nyre- og leverfunktion.
English: This medicinal product is a soluble insulin product consisting of the basal insulin degludec and the rapid-acting prandial insulin aspart.
Danish: Dette lægemiddel er et opløseligt insulinpræparat, som består af det langtidsvirkende basalinsulin insulin degludec og det hurtigtvirkende måltidsinsulin aspart.
English: There is no clinical experience with Ryzodeg during breast-feeding.
Danish: Der foreligger ingen kliniske erfaringer med anvendelse af Ryzodeg under amning.
English: If you are blind or have poor eyesight and cannot read the dose counter on the pen, do not use this insulin product without help.
Danish: Hvis du er blind eller har nedsat syn og ikke kan aflæse dosistælleren på pennen, må du ikke bruge dette insulinpræparat uden hjælp.
English: The basal component of Ryzodeg (insulin degludec) forms soluble multi-hexamers upon subcutaneous injection, resulting in a depot from which insulin degludec is continuously and slowly absorbed into the circulation leading to a flat and stable glucose-lowering effect.
Danish: Basalkomponenten i Ryzodeg (insulin degludec) danner efter subkutan injektion opløselige multihexamerer, hvorved der opstår et depot, hvorfra insulin degludec kontinuerligt og langsomt absorberes i kredsløbet og fører til den flade og stabile glucosesænkende virkning af Ryzodeg.
English: 5 After your injection • Lead the needle tip into the outer needle cap on a flat surface without touching the needle or the outer needle cap.
Danish: • Før nålespidsen ind i den ydre nålehætte, mens den ligger på en plan overflade, uden at røre ved nålen eller den ydre nålehætte.
English: Use only clear, colourless solution Single patient use only
Danish: Brug kun en klar, farveløs opløsning Kun til individuel brug
English: There is no clinical experience with the use of this medicinal product in children below the age of 2 years.
Danish: Der er ingen klinisk erfaring med brugen af dette lægemiddel hos børn under 2 år.
English: Always keep Ryzodeg Penfill in the outer carton when you are not using it in order to protect from light.
Danish: Opbevar altid Ryzodeg Penfill i den ydre karton, når den ikke er i brug, for at beskytte mod lys.
English: Ryzodeg 100 units/mL solution for injection in pre-filled pen EU/1/12/806/001
Danish: Ryzodeg 100 enheder/ml injektionsvæske, opløsning i fyldt pen EU/1/12/806/001
English: • monoamine oxidase (MAO) inhibitors, for depression
Danish: • monoaminoxidasehæmmere (MAO-hæmmere), mod depression
English: Swelling around your joints: When you first start using your medicine, your body may keep more water than it should.
Danish: Ikke almindelige bivirkninger (kan forekomme hos færre end 1 ud af 100 behandlede) Hævelse omkring leddene: Når du påbegynder behandling med lægemidlet, kan kroppen tilbageholde mere vand, end den skal.